TY - JOUR
T1 - Lung-protective ventilation initiated in the emergency department (LOV-ED)
T2 - A study protocol for a quasi-experimental, before-after trial aimed at reducing pulmonary complications
AU - Fuller, Brian M.
AU - Ferguson, Ian
AU - Mohr, Nicholas M.
AU - Stephens, Robert J.
AU - Briscoe, Cristopher C.
AU - Kolomiets, Angelina A.
AU - Hotchkiss, Richard S.
AU - Kollef, Marin H.
N1 - Funding Information:
BMF was funded by the KL2 Career Development Award, and this research was supported by the Washington University Institute of Clinical and Translational Sciences (Grants UL1 TR000448 and KL2 TR000450) from the National Center for Advancing Translational Sciences (NCATS). BMF was also funded by the Foundation for Barnes-Jewish Hospital Clinical and Translational Sciences Research Program (Grant # 8041-88). NMM was supported by grant funds from the Emergency Medicine Foundation and the Health Resources and Services Administration. RJS was supported by the Clinical and Translational Science Award (CTSA) programme of the NCATS of the National Institutes of Health (NIH) under Award Numbers UL1 TR000448 and TL1 TR000449. CCB was supported by the Short-Term Institutional Research Training Grant, NIH T35 (NHLBI). RSH was supported by NIH grants R01 GM44118-22 and R01 GM09839. MHK was supported by the Barnes-Jewish Hospital Foundation.
PY - 2016
Y1 - 2016
N2 - Introduction: In critically ill patients, acute respiratory distress syndrome (ARDS) and ventilator-associated conditions (VACs) are associated with increased mortality, survivor morbidity and healthcare resource utilisation. Studies conclusively demonstrate that initial ventilator settings in patients with ARDS, and at risk for it, impact outcome. No studies have been conducted in the emergency department (ED) to determine if lung-protective ventilation in patients at risk for ARDS can reduce its incidence. Since the ED is the entry point to the intensive care unit for hundreds of thousands of mechanically ventilated patients annually in the USA, this represents a knowledge gap in this arena. A lung-protective ventilation strategy was instituted in our ED in 2014. It aims to address the parameters in need of quality improvement, as demonstrated by our previous research: (1) prevention of volutrauma; (2) appropriate positive end-expiratory pressure setting; (3) prevention of hyperoxia; and (4) aspiration precautions. Methods and analysis: The lung-protective ventilation initiated in the emergency department (LOV-ED) trial is a single-centre, quasi-experimental before-after study testing the hypothesis that lungprotective ventilation, initiated in the ED, is associated with reduced pulmonary complications. An intervention cohort of 513 mechanically ventilated adult ED patients will be compared with over 1000 preintervention control patients. The primary outcome is a composite outcome of pulmonary complications after admission (ARDS and VACs). Multivariable logistic regression with propensity score adjustment will test the hypothesis that ED lung-protective ventilation decreases the incidence of pulmonary complications. Ethics and dissemination: Approval of the study was obtained prior to data collection on the first patient. As the study is a before-after observational study, examining the effect of treatment changes over time, it is being conducted with waiver of informed consent. This work will be disseminated by publicationof full-length manuscripts, presentation in abstract form at major scientific meetings and data sharing with other investigators through academically established means.
AB - Introduction: In critically ill patients, acute respiratory distress syndrome (ARDS) and ventilator-associated conditions (VACs) are associated with increased mortality, survivor morbidity and healthcare resource utilisation. Studies conclusively demonstrate that initial ventilator settings in patients with ARDS, and at risk for it, impact outcome. No studies have been conducted in the emergency department (ED) to determine if lung-protective ventilation in patients at risk for ARDS can reduce its incidence. Since the ED is the entry point to the intensive care unit for hundreds of thousands of mechanically ventilated patients annually in the USA, this represents a knowledge gap in this arena. A lung-protective ventilation strategy was instituted in our ED in 2014. It aims to address the parameters in need of quality improvement, as demonstrated by our previous research: (1) prevention of volutrauma; (2) appropriate positive end-expiratory pressure setting; (3) prevention of hyperoxia; and (4) aspiration precautions. Methods and analysis: The lung-protective ventilation initiated in the emergency department (LOV-ED) trial is a single-centre, quasi-experimental before-after study testing the hypothesis that lungprotective ventilation, initiated in the ED, is associated with reduced pulmonary complications. An intervention cohort of 513 mechanically ventilated adult ED patients will be compared with over 1000 preintervention control patients. The primary outcome is a composite outcome of pulmonary complications after admission (ARDS and VACs). Multivariable logistic regression with propensity score adjustment will test the hypothesis that ED lung-protective ventilation decreases the incidence of pulmonary complications. Ethics and dissemination: Approval of the study was obtained prior to data collection on the first patient. As the study is a before-after observational study, examining the effect of treatment changes over time, it is being conducted with waiver of informed consent. This work will be disseminated by publicationof full-length manuscripts, presentation in abstract form at major scientific meetings and data sharing with other investigators through academically established means.
UR - http://www.scopus.com/inward/record.url?scp=84971224850&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2015-010991
DO - 10.1136/bmjopen-2015-010991
M3 - Article
C2 - 27067896
AN - SCOPUS:84971224850
SN - 2044-6055
VL - 6
JO - BMJ Open
JF - BMJ Open
IS - 4
M1 - e010991
ER -